| Sector |
Healthcare
|
Compare with Sector peers |
| Industry |
Pharmaceuticals & Drugs
|
Compare with Industry peers |
| Website | http://www.fredungroup.com | |
| Market Cap | 397.14 Cr. | |
| Enterprise Value(EV) | 462.01 Cr. | 2023-09 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | 30.61 | Trailing Twelve Months Ending 2023-12 |
| Price-Earning Ratio (PE) | 27.48 | Trailing Twelve Months Ending 2023-12 |
| Industry PE | 41.74 | Trailing Twelve Months Ending 2023-12 |
| Book Value / Share | 252.22 | Trailing Twelve Months Ending 2023-12 |
| Price to Book Value | 3.33 | Calculated using Price: 841.10 |
| Dividend Yield | 0.08 | Period Ending 2023-03 |
| No. of Shares Subscribed | 0.47 Cr. | 4,721,662 Shares |
| FaceValue | 10 | |
| About Fredun Pharmaceuticals Ltd. | ||
| The company is engaged in manufacturing of pharmaceutical products. | ||
| 1 Day |
|
-0.39% |
| 1 Week |
|
+8.59% |
| 1 Month |
|
+14.61% |
| 3 Month |
|
-1.52% |
| 6 Month |
|
+0.99% |
| 1 Year |
|
+0.72% |
| 2 Year |
|
-31.85% |
| 5 Year |
|
+91.31% |
| 10 Year |
|
| 9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
| Return on Equity (%) | 9.68 | 33.46 | 33.88 | 13.02 | 14.59 | 4.74 | 4.77 | 11.42 | 13.86 | |
| Return on Capital Employed (%) | 14.23 | 24.67 | 18.16 | 15.9 | 20.56 | 10.36 | 9.53 | 13.15 | 18.35 | |
| Return on Assets (%) | 1.26 | 3.23 | 2.88 | 2.59 | 4.84 | 1.54 | 1.33 | 3.63 | 4.86 |
| Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
| Shh. Funds | 3 | 4 | 7 | 22 | 39 | 41 | 43 | 68 | 96 | 111 | |
| Non Curr. Liab. | 4 | 7 | 8 | 4 | 13 | 14 | 32 | 45 | 55 | 20 | |
| Curr. Liab. | 16 | 32 | 40 | 53 | 53 | 86 | 86 | 74 | 106 | 147 | |
| Minority Int. | |||||||||||
| Equity & Liab. | 23 | 43 | 56 | 79 | 105 | 141 | 162 | 187 | 257 | 279 | |
| Non Curr. Assets | 10 | 15 | 21 | 28 | 32 | 32 | 32 | 34 | 41 | 45 | |
| Curr. Assets | 13 | 28 | 35 | 51 | 73 | 109 | 130 | 153 | 216 | 234 | |
| Misc. Exp. not W/O | 0 | ||||||||||
| Total Assets | 23 | 43 | 56 | 79 | 105 | 141 | 162 | 187 | 257 | 279 |
| Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
| Net Sales | 25 | 42 | 57 | 60 | 97 | 113 | 134 | 224 | 275 | 311 | |
| Other Income | 0 | 1 | 2 | 0 | 1 | 1 | 1 | 2 | 2 | ||
| Total Income | 26 | 43 | 59 | 60 | 98 | 113 | 135 | 226 | 277 | 311 | |
| Total Expenditure | -24 | -38 | -53 | -54 | -87 | -104 | -125 | -211 | -246 | -271 | |
| PBIDT | 2 | 5 | 5 | 6 | 11 | 9 | 11 | 16 | 31 | 40 | |
| Interest | -1 | -2 | -2 | -2 | -3 | -4 | -4 | -5 | -10 | -13 | |
| Depreciation | -1 | -1 | -1 | -1 | -1 | -2 | -2 | -2 | -3 | -4 | |
| Taxation | 0 | -1 | -1 | -1 | -2 | -1 | -1 | -2 | -7 | -9 | |
| Exceptional Items | 0 | 0 | -1 | ||||||||
| PAT | 0 | 1 | 1 | 2 | 4 | 2 | 2 | 6 | 11 | 14 | |
| Adjusted EPS | 1 | 4 | 5 | 4 | 11 | 5 | 5 | 14 | 24 | 31 |
| Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
| Cash Fr. Operatn. | -1 | 2 | 3 | 4 | 17 | 1 | -11 | 0 | -2 | -14 | |
| Cash Fr. Inv. | -2 | -3 | -6 | -7 | -8 | -5 | -1 | -1 | -4 | -9 | |
| Cash Fr. Finan. | 2 | 1 | 3 | 3 | -8 | 4 | 14 | -1 | 7 | 25 | |
| Net Change | 0 | 0 | 1 | -1 | 1 | 0 | 2 | -2 | 1 | 1 | |
| Cash & Cash Eqvt | 0 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 2 | 3 |
|
Wed, 24 Apr 2024
Board Meeting Intimation for Prior Intimation For The Board Meeting Of The Company To Be Held On Tuesday 07Th May 2024. Fredun Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/05/2024 inter alia to consider and approve Notice is hereby given pursuant to Regulation 29 read with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 that the meeting of the Board of Directors of Fredun Pharmaceuticals Limited is scheduled to be held on Tuesday 07th May 2024 inter alia to consider and approve the following:1. Consider and approve Audited Financial Results for the Financial Year ended March 31 2024 along with the Statement of Assets and Liabilities and Cash Flow statement as on that date.2. Consider and recommend final dividend on the paid-up equity shares for the Financial Year ended March 31 2024. |
|
Mon, 15 Apr 2024
Board Meeting Outcome for Allotment Of 20 000 Equity Shares To Non-Promoter Upon Conversion Of Warrants Into Equity Shares Allotment of 20 000 Equity Shares to Non-Promoter upon conversion of Warrants into Equity Shares |
|
Mon, 15 Apr 2024
Compliance Certificate For The Period Ended March 31 2024 Compliance certificate for the period ended March 31 2024 |
| Thu, 25 Apr 2024 |
High Delivery Percentage
|
High Increase in 1 Month
|
William %R Trending Up
|
ROC Trending Up
|
Close Crossing 100 SMA From Below
|
